Association of interleukin-1β levels in type 2 diabetes mellitus patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253320Keywords:
Type 2 Diabetes Mellitus, Interleukin-1β, HbA1C, InflammationAbstract
Background: Type 2 diabetes mellitus (T2DM) is a complex, non-communicable illness mainly marked by two main features: insulin resistance and chronic inflammation. Interleukin-1β (IL-1β) has been implicated in metabolic processes including insulin secretion and b-cell apoptosis. Increased levels of pro-inflammatory markers such as IL-1β, tumor necrosis factor-α and adipokines has been reported in T2DM patients. Recent studies have demonstrated a positive correlation between Interleukins in T2DM patients. The objective of the study was to find association of IL-1β in T2DM patients.
Methods: We conducted a cross-sectional study among T2DM patients visiting the OPD of Pulmonary Medicine. T2DM patients aged between 40 to 65 years of either sex were recruited. Biochemical investigations were performed in blood sample.
Results: We recruited 340 T2DM patients (162 males and 178 females) for the present study. Biochemical analysis viz. Plasma glucose and HbA1c reported 78 subjects with uncontrolled diabetes and 262 subjects with controlled diabetes. IL-1β levels were found to be significantly increased (p<0.001, t=21.76) in uncontrolled diabetics (55.23±9.11) in comparison with controlled diabetics (25.39±11.04).
Conclusions: Results suggests a highly significant and positive (p<0.001) association of IL-1β with glucose levels in T2DM patients.
Metrics
References
Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society; Geriatric Professional Committee of Beijing Medical Award Foundation; National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital). Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition). Zhonghua Nei Ke Za Zhi. 2022;61(1):12-50.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. DOI: https://doi.org/10.1038/nrendo.2017.151
Kohlgruber A, Lynch L. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2015;15(11):92. DOI: https://doi.org/10.1007/s11892-015-0670-x
Cronkite DA, Strutt TM. The Regulation of Inflammation by Innate and Adaptive Lymphocytes. J Immunol Res. 2018;1-14. DOI: https://doi.org/10.1155/2018/1467538
Rathinam VAK, Chan FKM. Inflammasome, Inflammation, and Tissue Homeostasis. Trends Mol. Med. 2018;24:304-18. DOI: https://doi.org/10.1016/j.molmed.2018.01.004
Eguchi K, Manabe I, Oishi-Tanaka Y, Ohsugi M, Kono N, Ogata F, et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metabolism. 2012;15:518-33. DOI: https://doi.org/10.1016/j.cmet.2012.01.023
Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. The interleukin (IL)-1 cytokine family-Balance between agonists and antagonists in inflammatory diseases. Cytokine. 2015;76(1):25-37. DOI: https://doi.org/10.1016/j.cyto.2015.06.017
Tang SCW, Yiu WH. Innate Immunity in Diabetic Kidney Disease. Nat Rev Nephrol. 2020;16:206-22. DOI: https://doi.org/10.1038/s41581-019-0234-4
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in Obesity, Diabetes, and Related Disorders. Immunity. 2022;55:31-55. DOI: https://doi.org/10.1016/j.immuni.2021.12.013
Suwara MI, Green NJ, Borthwick LA, Mann J, Mayer-Barber KD, Barron L, et al. IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2014;7:684-93. DOI: https://doi.org/10.1038/mi.2013.87
Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab. 2008;93(10):4065-74. DOI: https://doi.org/10.1210/jc.2008-0396
Alfadul H, Sabico S and Al-Daghri NM. The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol. 2022;13:901616. DOI: https://doi.org/10.3389/fendo.2022.901616
Kubysheva NI, Postnikova LB, Soodaeva SK, Novikov DV, Eliseeva TI, Novikov VV, et al. Comparative Study of the Levels of IL-1β, IL-4, IL-8, TNFα, and IFNγ in Stable Course and Exacerbation of Chronic Obstructive Pulmonary Disease of Varying Severity. Bull Exp Biol Med. 2022;173(6):745-8. DOI: https://doi.org/10.1007/s10517-022-05622-z
American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;33:S62-9. DOI: https://doi.org/10.2337/dc10-S062
Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-21. DOI: https://doi.org/10.1016/S0140-6736(09)60619-X
Zhang W, Li C, Xu Y, He B, Hu M, Cao G, et al. Hyperglycemia and correlated high levels of inflammation have a positive relationship with the severity of coronavirus disease 2019. Mediat Inflamm. 2021;18:8812304. DOI: https://doi.org/10.1155/2021/8812304
Rissanen A, Howard CP, Botha J, Thuren T. Effect of anti-IL-1b antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo controlled trial. Diabetes Obesity Metab. 2012;14:1088-96. DOI: https://doi.org/10.1111/j.1463-1326.2012.01637.x
Sousa AR, Lane SJ, Nakhosteen JA, Lee TH, Poston RN. Expression of interleukin-1b and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med. 1996;154:1061-6. DOI: https://doi.org/10.1164/ajrccm.154.4.8887608
Haamid B, Sabhiya M, Mosin SK, Mohammad HB, Rabia H, Roohi A et al. Inter-relationship of Pro- and Anti- inflammatory Biomarkers with the development of Type 2 Diabetes Mellitus. Heliyon. 2022;8(11):e11329. DOI: https://doi.org/10.1016/j.heliyon.2022.e11329
Vahid P, Sarmad M, Mohammad SY. Investigation of serum level relationship anti-glutamic acid decarboxylase antibody and inflammatory cytokines (IL-1β, IL-6) with vitamins D in type 2 diabetes. J Diabetes Metab Disord. 2022;13:21(1):181-7. DOI: https://doi.org/10.1007/s40200-021-00956-3
Jin Q, Ying H. Expression of TNF- α and IL-1β in Peripheral Blood of Patients with T2DM Retinopathy. Comput Math Methods Med. 2022;8:9073372. DOI: https://doi.org/10.1155/2022/9073372
Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2000;23(4):530-6. DOI: https://doi.org/10.1165/ajrcmb.23.4.3959
Downloads
Published
How to Cite
Issue
Section
